CA2626085C - S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same - Google Patents

S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same Download PDF

Info

Publication number
CA2626085C
CA2626085C CA2626085A CA2626085A CA2626085C CA 2626085 C CA2626085 C CA 2626085C CA 2626085 A CA2626085 A CA 2626085A CA 2626085 A CA2626085 A CA 2626085A CA 2626085 C CA2626085 C CA 2626085C
Authority
CA
Canada
Prior art keywords
strontium
omeprazole
crystalline
tetrahydrate
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2626085A
Other languages
English (en)
French (fr)
Other versions
CA2626085A1 (en
Inventor
Tae Hee Ha
Hee Sook Oh
Won Jeoung Kim
Chang Hee Park
Eun Young Kim
Young Hoon Kim
Kwee Hyun Suh
Gwan Sun Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanmi Science Co Ltd
Original Assignee
Hanmi Holdings Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Holdings Co Ltd filed Critical Hanmi Holdings Co Ltd
Publication of CA2626085A1 publication Critical patent/CA2626085A1/en
Application granted granted Critical
Publication of CA2626085C publication Critical patent/CA2626085C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA2626085A 2005-10-26 2006-10-25 S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same Expired - Fee Related CA2626085C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR10-2005-0101059 2005-10-26
KR20050101059 2005-10-26
KR2006000760 2006-03-06
KRPCT/KR2006/000760 2006-03-06
PCT/KR2006/004369 WO2007049914A1 (en) 2005-10-26 2006-10-25 S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same

Publications (2)

Publication Number Publication Date
CA2626085A1 CA2626085A1 (en) 2007-05-03
CA2626085C true CA2626085C (en) 2011-12-06

Family

ID=37967988

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2626085A Expired - Fee Related CA2626085C (en) 2005-10-26 2006-10-25 S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same

Country Status (8)

Country Link
JP (1) JP5017274B2 (ru)
AU (1) AU2006306906B2 (ru)
CA (1) CA2626085C (ru)
IL (1) IL190709A (ru)
MY (1) MY140986A (ru)
NO (1) NO20082358L (ru)
RU (1) RU2372345C1 (ru)
WO (1) WO2007049914A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576219B2 (en) 2005-10-26 2009-08-18 Hanmi Pharm. Co., Ltd Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
CN116102538A (zh) * 2023-01-29 2023-05-12 山东省分析测试中心 一种转晶制备三水合艾司奥美拉唑镁的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
WO2004099182A1 (en) * 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Zinc salt of (s)-omeprazole
SI1651217T1 (sl) * 2003-07-23 2008-08-31 Nycomed Gmbh Alkalne soli inhibitorjev protonske ÄŤrpalke
KR20080007508A (ko) * 2005-05-06 2008-01-21 그렌마크 파머수티칼스 엘티디. 에소메프라졸 스트론튬염, 그것의 제조방법 및 그것을함유하는 약제학적 조성물

Also Published As

Publication number Publication date
JP2009513625A (ja) 2009-04-02
AU2006306906B2 (en) 2010-02-04
NO20082358L (no) 2008-07-25
MY140986A (en) 2010-02-12
JP5017274B2 (ja) 2012-09-05
WO2007049914A1 (en) 2007-05-03
CA2626085A1 (en) 2007-05-03
IL190709A0 (en) 2008-11-03
RU2372345C1 (ru) 2009-11-10
IL190709A (en) 2012-03-29
AU2006306906A1 (en) 2007-05-03

Similar Documents

Publication Publication Date Title
US8586752B1 (en) Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
CA2597632C (en) Substituted sulfoxide compounds, methods for preparing the same and use thereof
EP1674463A1 (en) Rabeprazole sodium salt in crystalline hydrate form
CA2626085C (en) S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same
US8592601B2 (en) Precursor phase and use thereof for preparing the magnesium tetrahydrate salt of an omeprazole enantiomer
MXPA05001168A (es) Sal de (s)-pantoprazol y sus hidratos.
WO2006001755A1 (en) A new esomeprazole sodium salt crystal modification
EP1598347A1 (en) Polymorphs of pantoprazole sodium salt and process for the preparation thereof
US9034904B2 (en) Forms of dexlansoprazole and processes for the preparation thereof
KR101459088B1 (ko) 알-라베프라졸, 이의 금속염의 제조방법
KR20130063762A (ko) 신규 에스라베프라졸, 이의 알칼리금속 및 알칼리토금속염 및 이의 제조방법
CZ12613U1 (cs) Chemická sloučenina amlodipinaspartát a farmaceutický prostředek

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20181025